Boston Scientific Corporation, Terumo Vietnam Medical Equipment Co., Ltd. (A Subsidiary of Terumo Medical Corporation), and Abbott dominated the Vietnam Interventional Cardiology Market in 2020

Vietnam Interventional Cardiology Market is expected to grow with a CAGR of 6.8% in the forecast period of 2021 to 2028. The years considered for the study are as mentioned below:

Access Full Report @ https://www.databridgemarketresearch.com/reports/vietnam-interventional-cardiology-market

The Vietnam interventional cardiology market is a highly consolidated market, including a specific number of key players. The market has witnessed increased strategic developments owing to favourable market scenarios.    

The major players dealing in the Vietnam interventional cardiology market are introducing a strong range of product providers, launching new products, and adopting strategic initiatives such as acquisition and agreement. This helped companies to maximize sales with an enhanced product portfolio.

For instance,

  • In April 2021, Abbott announced that it had received CE Mark for the TriClip Trans catheter tricuspid valve repair system in the Asia-Pacific region to treat tricuspid regurgitation. This helped the company in diversifying its business

Boston Scientific Corporation is the dominating player in the Vietnam interventional cardiology market. The other key players existing in the market include Medtronic, Teleflex Incorporated, Terumo Vietnam Medical Equipment Co., Ltd (A Subsidiary of Terumo Corporation), Abbott, B. Braun Melsungen AG, USM HEALTHCARE, BIOTRONIK, Stryker, Philips Electronics N.V. (A subsidiary of Koninjlkjke Philps NV), BD, Medinol Ltd., AngioDynamics, among others.

Vietnam Interventional Cardiology MarketBoston Scientific Corporation

Boston Scientific Corporation was founded in the year 1979 and is headquartered in Massachusetts, U.S. It has public ownership. The company provides kits, reagents, instruments, and services that help researchers explore questions about gene discovery, regulation, and function. The company has various business segments such as Medical-Surgical (MedSurg), Rhythm and Neuro, and Cardiovascular, amongst which Cardiovascular is the market-focused segment. The company operates via various product categories such as Ablation Access Device Dilatation, Access Device, Sheath Accessories, Atherectomy Systems, Balloons Dilation, and Extraction, Band Ligator Baskets, Bronchial Thermoplasty, Catheters Balloon Catheters, Diagnostic Catheters, Drainage Catheter, Guide Catheters, Support Catheters, Ureteral Clips, CRT-DCRT-PCTO Systems, Deep Brain Stimulation Systems, Defibrillators (S-ICD, ICD), Direct Visualization Systems, Embolic Protection, Embolization FFR & IVUS Systems Forceps, Guidewires Imaging Systems Leads Needles, Pacemakers PCNL, Plaque Modification Remote Patient Monitoring, Retrieval Devices, Snares Sphincterotomes, Spinal Cord Stimulator Systems, Stents, Coronary Stents, Gastrointestinal Stents, Pulmonary Stents, Ureteral Stents, Vascular Thrombectomy Systems, Ablation. The market-focused categories are Balloons, Dilation and Extraction Band, Catheters, Balloon Catheters, Diagnostic Catheters, Drainage Catheters Guide Catheters, Support Catheters, Systems Stents, Coronary, Stents.

For instance,

  • In September 2020, Boston Scientific Corporation had declared the investment agreement with an exclusive option to acquire Farapulse, Inc., a privately-held company developing a pulsed-field ablation (PFA) system and catheterization for the treatment of atrial fibrillation (A.F.) and other cardiac arrhythmias. This PFA system – comprising a sheath, generator, and catheters – is intended to ablate heart tissue by creating a therapeutic electric field instead of using thermal energy sources such as radiofrequency ablation or cryoablation. The investment would further progress the U.S. regulatory approval. It would show positive growth in the market

The company has a presence across North America, Europe, Asia-Pacific, the Middle East and Africa. The company has various subsidiaries such as Acurate Industria e Comercio Ltda. (Brazil), American Medical Systems Europe B.V. (Netherlands),Apama Medical, Inc. (U.S.), Augmenix, Inc. (U.S.), and Biocompatibles International Limited (England) among others.

Terumo Vietnam Medical Equipment Co., Ltd (A Subsidiary of Terumo Corporation)

Terumo Vietnam Medical Equipment Co., Ltd (A Subsidiary of Terumo Corporation) was founded in 2012 and is headquartered in Hanoi City, Vietnam. It has private ownership. The company engages in the manufacturing and sale of medical products and equipment. Cardiac and Vascular Company, General Hospital Company, and Blood and Cell Technologies Company are the company's product categories. Under which Cardiac and Vascular Company is the market-focused category.

For instance,

  • In June 2020, Terumo Corporation announced it has entered into a strategic partnership with Orchestra BioMed, Inc. and has secured extensive global development and commercialization rights to eluting balloon for percutaneous coronary intervention. This helped the company to enhance its cardic and vascular portfolio

The company has a presence across the Asia-Pacific.

Abbott

Abbott was founded in 1888 and is headquartered in Illinois, U.S. It has public ownership. The company focuses on the manufacturing of devices to manage chronic pain and diabetes, among others. The company has various business segments such as Established Pharmaceutical Products, Nutritionals, Diagnostics, Medical Devices, Other. Under which Medical Devices is the market-focused segment. Cardiovascular, Diabetes Care, Diagnostics, Neuromodulation, Nutrition, and Medicines are product categories. Amongst them, Cardiovascular is the market-focused category.

For instance,

  • In December 2020, Abbott participated in the 39th Annual J. P. Morgan Healthcare Conference. This has helped the company to discuss its best product which helped the company to grow in the coming years

The company has a presence across Americas, Europe, the Middle East and Africa, Asia-Pacific. The company has subsidiaries such as Abbott Cardiovascular Systems Inc. (U.S.), Abbott Nutrition Manufacturing Inc. (U.S.), Abbott Laboratories Pacific Ltd. (U.S.), Abbott Resources Inc. (U.S.), and PDD II, LLC (U.S.), among others.